Peanuts for Cardiometabolic, Brain, and Intestinal Health
Recruiting · NCT06867198 · Interventional (participants receive a specific treatment) · Lead sponsor: Georgia State University
View the official record on ClinicalTrials.gov →Interventions studied
Peanuts
What this trial is about
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
Who can take part
Age range
20 Years to 59 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- men and women
- 20-59 years of age
- BMI: 24.5 - 35.5 kg/m\^2
- Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)
- Ability to give consent
Exclusion criteria
- Allergies to peanuts and peanut products
- Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
- Active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological diseases or severe head injury
- Smoking
- Consumes greater than 2 alcoholic beverages per day
- Consumes antioxidant, probiotic, and prebiotic supplements
- Pregnant or Lactating
- Actively participating in a weight loss program
- MRI Exclusion Criteria:
- Certain neurological disorders (e.g., uncontrolled seizure disorders)
- Braces on their teeth, a cardiac pacemaker; hearing aid; other metal in the body or eyes (which may include certain metallic-embedded tattoos), including but not limited to pins, screws, shrapnel, plates, dentures or other metal objects
Where it is running
1 location listed across 1 US state.
- Georgia State University - Atlanta, Georgia, United States